Name

IKOMED Technologies Inc.

Legal name

IKOMED Technologies Inc.

Website

https://ikomed.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

X-ray & Fluoroscopy Systems (HLAHABAA)

akta.pro secondary industries

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG), Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

Keywords

• AI-guided radiation reduction
• Medical device technology
• Fluoroscopy imaging systems
• Emphysema treatment devices
• Radiofrequency therapy

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. AEGIS Technology Licensing and Integration: IKOMED provides AEGIS technology to Omega Medical Imaging, which integrates it into their fluoroscopy systems and commercializes as FluoroShield in the US market. Revenue generated through this OEM partnership arrangement.
2. Medical Device Sales (via Partner): FluoroShield systems incorporating AEGIS are FDA cleared and sold commercially to hospitals in the USA through Omega Medical Imaging distribution channel.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels8 records

Core offering

IKOMED Technologies Inc. develops and manufactures proprietary medical device technologies, primarily the AEGIS AI-guided X-ray radiation reduction system for fluoroscopy procedures (commercialized as FluoroShield through partner Omega Medical Imaging) and ATMOS, a noninvasive radiofrequency device for the treatment of emphysema/COPD. The company conducts R&D, manufacturing, integration, and testing from its Vancouver office and licenses/integrates AEGIS into partner fluoroscopy systems sold to US hospitals.

Product overview

IKOMED Technologies Inc. is a Vancouver-based medical device company offering two distinct technology platforms. The first is AEGIS (commercially marketed as FluoroShield™), an FDA-cleared AI-powered system that uses computer vision and electromechanical shutter technology to reduce X-ray radiation exposure during fluoroscopy-guided procedures by over 60%. The second is ATMOS, a proprietary noninvasive device using extracorporeal radiofrequency energy for the treatment of emphysema, currently in preclinical testing phase.

Differentiator

Problem solved

Functional benefit

Brands

• FluoroShield: AI-powered Region of Interest radiation exposure reduction solution marketed by Omega Medical Imaging in the USA, based on IKOMED's AEGIS technology
• AEGIS
• ATMOS

Products and services

• AEGIS AI-guided X-ray radiation reduction system for fluoroscopy that uses machine learning and electromechanical shutter technology to reduce X-ray radiation exposure during minimally invasive procedures by over 60%, as proven in clinical studies. Integrated into partner fluoroscopy systems for sale to US hospitals.
• ATMOS Proprietary noninvasive device for the treatment of emphysema (a type of COPD) using extracorporeal radiofrequency energy. Applies RF energy externally to selectively target diseased lung tissue, inducing tissue remodeling and shrinking of diseased areas, with the goal of slowing emphysema progression and improving lung function. Currently in preclinical testing phase.
• FluoroShield Commercial brand name for the FDA-cleared AEGIS technology, marketed by Omega Medical Imaging in the USA. Combines AI, ultra-fast collimator, and advanced image processing to deliver a Region of Interest (ROI) radiation exposure reduction solution for interventional X-ray imaging systems.

Quantifiable outcome

• Reduces X-ray radiation in fluoroscopy by over 60% without degrading image quality
• +3 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

Partnerships

One partnership is on record.

• Omega Medical ImagingcoreChannel Partner/ Reseller/ DistributorStrategic partnership for AEGIS technology commercialization. Omega Medical Imaging integrates IKOMED's AEGIS AI-powered radiation reduction technology into their fluoroscopy systems and markets it as FluoroShield in the US. Multiple FDA-cleared systems are sold commercially to hospitals through this partnership. Omega is an innovator in design, manufacture, and support of Interventional X-Ray Imaging devices for hospitals and healthcare facilities globally.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Shimadzu: Japanese manufacturer of interventional X-ray/fluoroscopy systems used in cardiology and GI ERCP. Competes for the same hospital fluoroscopy procurement dollars and represents a potential additional OEM channel for AEGIS.
• Canon Medical Systems: Manufacturer of diagnostic and interventional fluoroscopy/angiography systems with AI-enabled imaging features. Direct competitor to Omega Medical Imaging in the fluoroscopy OEM space.
• GE HealthCare: Major interventional imaging OEM with AI image processing and dose management features on its Innova fluoroscopy systems. Operates in the same procedure space (cardiac, ERCP) where AEGIS is deployed.
• Siemens Healthineers: Global interventional X-ray and imaging incumbent with AI-driven dose-reduction features across its angiography/fluoroscopy portfolio. Serves the same hospitals as IKOMED/Omega; represents both a competitive threat and a potential future OEM partner.
• Philips Healthcare: Global interventional X-ray vendor (Azurion platform) with AI-driven image processing and dose management. Targets the same hospital departments as AEGIS/FluoroShield.

Direct peers

• Pulmonx: Commercial-stage company offering the Zephyr endobronchial valve for lung volume reduction in severe emphysema. Most directly comparable alternative to ATMOS within the same patient population and clinical use case (non-drug emphysema intervention).
• Omega Medical Imaging: Strategic OEM partner that commercializes IKOMED's AEGIS as FluoroShield on its interventional X-ray systems. Operates in the same AI-enabled fluoroscopy product category and shares the same end customers (US hospitals), making it the closest comparable to IKOMED's commercialized product.

Emerging players

• Aidoc: AI platform for radiology image analysis (CT, X-ray) deployed in hospital radiology departments. Partial overlap with AEGIS — both apply computer vision/AI to medical imaging, addressing similar clinical workflow integration challenges.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ikomed-technologies-inc-

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IKOMED Technologies Inc.